References
Original articles
Morand, E. F. et al. Baricitinib for systemic lupus erythematosus: a double blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-I). Lancet https://doi.org/10.1016/S0140-6736(22)02607-1 (2023)
Petri, M. et al. Baricitinib for systemic lupus erythematosus: a double blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-II). Lancet https://doi.org/10.1016/S0140-6736(22)02546-6 (2023)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
McHugh, J. BRAVE news: another one bites the dust. Nat Rev Rheumatol 19, 255 (2023). https://doi.org/10.1038/s41584-023-00957-x
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41584-023-00957-x
- Springer Nature Limited